Samsung Bioepis Nl B.V.
SpainAll drugs from this manufacturer
-
It is used to treat several types of cancer in adults, including advanced colon or rectal cancer, metastatic breast cancer, advanced non-small cell lung cancer, advanced renal cancer, primary epithelial ovarian, fallopian tube, or peritoneal cancer, and persistent, recurrent, or metastatic cervical cancer.
Dosage form: solution for infusion, concentrate
Active substance Dosage bevacizumab 25 mg/ml -
It is used to treat rheumatoid arthritis (moderate or severe), psoriatic arthritis, axial spondyloarthritis (including ankylosing spondylitis), and plaque psoriasis (moderate or severe). It is also prescribed to children and adolescents with certain forms of juvenile idiopathic arthritis and plaque psoriasis, provided they meet specific weight and age requirements.
Dosage form: solution for injection
Active substance Dosage etanercept 25 mg -
It is used to treat rheumatoid arthritis (moderate or severe), psoriatic arthritis, severe axial spondyloarthritis (including ankylosing spondylitis), and moderate or severe plaque psoriasis. It is also prescribed in children and adolescents for certain types of juvenile idiopathic arthritis and severe plaque psoriasis, provided they meet the specified weight and age requirements.
Dosage form: solution for injection in pre-filled pen
Active substance Dosage etanercept 50 mg -
It is used to treat moderate to severe rheumatoid arthritis, psoriatic arthritis, severe axial spondyloarthritis (including ankylosing spondylitis), and moderate to severe plaque psoriasis. It is also prescribed for children and adolescents with certain types of juvenile idiopathic arthritis and severe plaque psoriasis, provided they meet a specific body weight requirement.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage etanercept 50 mg -
It is used to treat adults and children with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), diseases that affect the blood system and, in the case of aHUS, also the kidney.
Dosage form: solution for infusion, concentrate
Active substance Dosage eculizumab 300 mg -
It is used in adults to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis (Bechterew's disease), and psoriasis. It is also prescribed in adults and children aged 6 years and older for Crohn's disease and ulcerative colitis.
Dosage form: powder for concentrate for solution for infusion
Active substance Dosage infliximab 100.00 mg -
It is used to treat various inflammatory diseases such as rheumatoid arthritis, psoriatic arthritis, psoriasis, Crohn's disease, ulcerative colitis, hidradenitis suppurativa, ankylosing spondylitis, non-infectious uveitis, and polyarticular juvenile idiopathic arthritis.
Dosage form: solution for injection in pre-filled pen
Active substance Dosage adalimumab 40 mg -
It is used to treat various inflammatory diseases such as rheumatoid arthritis, psoriatic arthritis, psoriasis, Crohn's disease, ulcerative colitis, hidradenitis suppurativa, ankylosing spondylitis, non-infectious uveitis, and other joint and skin conditions.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage adalimumab 40 mg -
It is used to treat postmenopausal osteoporosis in women and osteoporosis in men at risk of fracture. It is also used to treat bone loss caused by testosterone reduction in patients with prostate cancer or bone loss due to prolonged glucocorticoid use.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage denosumab 60 mg -
It is used to treat early or metastatic breast cancer, as well as metastatic gastric cancer, provided they exhibit high levels of the HER2 protein.
Dosage form: powder for concentrate for solution for infusion
Active substance Dosage trastuzumab 150 mg -
It is prescribed for the treatment of breast cancer (either early or metastatic) or metastatic gastric cancer, provided that high levels of the HER2 protein are present.
Dosage form: powder for concentrate for solution for infusion
Active substance Dosage trastuzumab 420 mg -
It is used to treat moderate to severe Crohn's disease in adults and in children weighing at least 40 kg.
Dosage form: solution for infusion, concentrate
Active substance Dosage ustekinumab 130 mg -
It is used to treat inflammatory diseases such as plaque psoriasis (in adults and children aged 6 years and older), psoriatic arthritis (in adults), and Crohn's disease (in adults and children weighing at least 40 kg).
Dosage form: solution for injection
Active substance Dosage ustekinumab 45 mg -
It is used to treat inflammatory diseases in adults, specifically plaque psoriasis (moderate to severe), psoriatic arthritis, and Crohn's disease (moderate to severe).
Dosage form: solution for injection in pre-filled pen
Active substance Dosage ustekinumab 45 mg -
It is used to treat inflammatory diseases such as plaque psoriasis (in adults and children aged 6 years and older), psoriatic arthritis (in adults), and Crohn's disease (in adults and children weighing at least 40 kg).
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage ustekinumab 45 mg -
It is used to treat inflammatory diseases in adults, specifically plaque psoriasis, psoriatic arthritis, and moderate to severe Crohn's disease.
Dosage form: solution for injection in pre-filled pen
Active substance Dosage ustekinumab 90 mg -
It is used to treat inflammatory diseases such as plaque psoriasis (in adults and children aged 6 years and older), psoriatic arthritis (in adults), and Crohn's disease (in adults and children weighing at least 40 kg).
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage ustekinumab 90 mg -
It is used in adults with advanced cancer to prevent serious complications caused by bone metastases (such as fractures or spinal cord compression) and to treat giant cell bone tumor in adults and adolescents whose bones have stopped growing.
Dosage form: solution for injection
Active substance Dosage denosumab 120 mg